Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin aspart effects on postprandial platelet activation in type 2 diabetes
2006-007031-27Phase 4Completed
- Sponsor
- Karolinska Institutet
- Start
- Feb 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin aspart in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Karolinska Institutet. Primary endpoints: Treatment effect on postprandial platelet activation, U46619-stimulated platelet P-selectin expression and 3 more. Started Feb 2007; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-007031-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-007031-27.